4 May 2017 07:00
Venture Life Group plc
("Venture Life" or the "Company")
Change of Adviser
Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it has appointed Northland Capital Partners as its nominated adviser and joint broker with immediate effect.
For further information please contact:
Venture Life Group PLC | +44 (0) 1344 742870 | |
Jerry Randall, Chief Executive Officer | ||
Adrian Crockett, Chief Financial Officer | ||
Northland Capital Partners Limited (Nominated Adviser and Joint Broker) | +44 (0) 20 3861 6625 | |
Matthew Johnson / Edward Hutton / Margarita Mitropoulou (Corporate Finance) | ||
Bob Pountney / John Howes (Corporate Broking) | ||
Turner Pope Investments (TPI) Ltd (Joint Broker) | +44 (0) 20 3621 4120 | |
James Pope / Ben Turner | ||
Walbrook PR | venturelife@walbrookpr.com or + 44 (0) 20 7933 8780 | |
Paul McManus / Anna Dunphy | +44 (0) 7980 541 893 / +44 (0) 7876 741 001 | |
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
Venture Life (VLG)